Psychiatric medication-induced obesity: treatment options

Area of Science:

• Psychiatry
• Pharmacology
• Endocrinology

Background:

• Weight gain and obesity are common side effects of psychiatric medications, including antidepressants, antipsychotics, and mood stabilizers.
• This metabolic complication can negatively impact patient adherence and overall health outcomes.
• Current management strategies lack FDA approval and robust scientific evidence.

Purpose of the Study:

• To conduct a comprehensive literature review on novel treatment options for managing medication-induced weight gain.
• To synthesize existing research on interventions for weight gain associated with antidepressants, antipsychotics, and mood stabilizers.
• To identify gaps in current research and highlight the need for future studies.

Main Methods:

• Comprehensive literature search of relevant scientific databases.
• Systematic review and synthesis of findings from existing studies on weight management interventions.
• Analysis of the efficacy and limitations of current and emerging treatment options.

Main Results:

• Limited evidence exists for effective interventions, with most studies being small-scale and uncontrolled.
• No specific agents are currently FDA-approved for managing psychiatric medication-induced weight gain.
• Several novel therapeutic avenues are under investigation, showing potential for future application.

Conclusions:

• There is a significant unmet need for effective and approved treatments to manage weight gain caused by psychiatric medications.
• Larger, well-controlled studies are crucial to validate the efficacy of existing and emerging interventions.
• Development of future psychotropic medications with reduced metabolic side effects is a key area for advancement.